Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Increasing BMI and waist circumference and prevalence of obesity among adults with Type 2 diabetes: the National Health and Nutrition Examination Surveys.

Kramer H, Cao G, Dugas L, Luke A, Cooper R, Durazo-Arvizu R.

J Diabetes Complications. 2010 Nov-Dec;24(6):368-74. doi: 10.1016/j.jdiacomp.2009.10.001. Epub 2009 Nov 14.

PMID:
19914095
2.

Impact of race/ethnicity on the relationship between visceral fat and inflammatory biomarkers.

Carroll JF, Fulda KG, Chiapa AL, Rodriquez M, Phelps DR, Cardarelli KM, Vishwanatha JK, Cardarelli R.

Obesity (Silver Spring). 2009 Jul;17(7):1420-7. doi: 10.1038/oby.2008.657. Epub 2009 Feb 5.

3.
4.

Adipocytokines and the metabolic complications of obesity.

Rasouli N, Kern PA.

J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S64-73. doi: 10.1210/jc.2008-1613. Review.

5.

Role of body fat distribution and the metabolic complications of obesity.

Jensen MD.

J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S57-63. doi: 10.1210/jc.2008-1585. Review.

6.

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.

Hajer GR, van Haeften TW, Visseren FL.

Eur Heart J. 2008 Dec;29(24):2959-71. doi: 10.1093/eurheartj/ehn387. Epub 2008 Sep 5. Review.

PMID:
18775919
7.

Effects of exercise on adipokines and the metabolic syndrome.

You T, Nicklas BJ.

Curr Diab Rep. 2008 Feb;8(1):7-11. Review.

PMID:
18366992
8.

Insulin resistance -- the role of ethnicity: evidence from Caucasian and African cohorts.

Reimann M, Schutte AE, Schwarz PE.

Horm Metab Res. 2007 Dec;39(12):853-7. Review.

PMID:
18075967
10.

Relationship between adipocyte size and adipokine expression and secretion.

Skurk T, Alberti-Huber C, Herder C, Hauner H.

J Clin Endocrinol Metab. 2007 Mar;92(3):1023-33. Epub 2006 Dec 12.

PMID:
17164304
11.

Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai.

Chanchay S, Tungtrongchitr R, Harnroongroj T, Phonrat B, Rungseesakorn O, Paksanont S, Pooudong S, Saowakontha S, Varongchayakul C.

Int J Vitam Nutr Res. 2006 May;76(3):125-31.

PMID:
17048191
12.

Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.

Kim C, Park J, Park J, Kang E, Ahn C, Cha B, Lim S, Kim K, Lee H.

Obesity (Silver Spring). 2006 Jul;14(7):1164-71.

13.

Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression.

Jernås M, Palming J, Sjöholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjögren A, Rudemo M, Lystig TC, Carlsson B, Carlsson LM, Lönn M.

FASEB J. 2006 Jul;20(9):1540-2. Epub 2006 Jun 5.

PMID:
16754744
14.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

15.
16.

Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes.

Yang Y, Lu HL, Zhang J, Yu HY, Wang HW, Zhang MX, Cianflone K.

Int J Obes (Lond). 2006 Mar;30(3):439-46.

PMID:
16302015
17.

Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.

Al-Harithy RN, Al-Ghamdi S.

Ann Saudi Med. 2005 Jul-Aug;25(4):283-7.

18.

Adipose development: from stem cell to adipocyte.

Otto TC, Lane MD.

Crit Rev Biochem Mol Biol. 2005 Jul-Aug;40(4):229-42. Review.

PMID:
16126487
19.

Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.

Hasegawa G, Ohta M, Ichida Y, Obayashi H, Shigeta M, Yamasaki M, Fukui M, Yoshikawa T, Nakamura N.

Acta Diabetol. 2005 Jun;42(2):104-9.

PMID:
15944845
20.

Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.

Putz DM, Goldner WS, Bar RS, Haynes WG, Sivitz WI.

Metabolism. 2004 Nov;53(11):1454-61.

PMID:
15536601

Supplemental Content

Support Center